Please assess the completion status of the following clinical trial:

Trial Title: Oral Rehydration Therapy in Burn Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients aged 18-65 years~* Partial- to full-thickness burn injuries involving 20-65% of total body surface area (TBSA)~Exclusion Criteria:~* Presence of inhalation injury~* Hypotension or shock~* Concomitant serious traumatic injury (i.e. head/ spine trauma)~* Gastric Bypass Surgery~* Small Bowel Obstruction~* Delay in resuscitation \>2 hrs.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Ceralyte 90 (Type: EXPERIMENTAL): Ceralyte® will be administered during the first 24-hours post-burn. Fluid requirements will be calculated according to the Parkland Formula with 50% administered during the first 8 hours and the second 50% administered over the next 16 hours. During the first 2 hours IV fluids will be started at the Parkland goal minus 250cc, which will be administered using Ceralyte via oral, nasogastric (NG), or dobhoff tube. ORT and IV fluids will be monitored with additional doses given hourly. Urine output will be monitored hourly and gastric residuals will be monitored every 2 hours, with adjustments made as needed to ensure adequate fluid resuscitation.

Based on this trial design, predict the completion outcome and termination type (if applicable).